Holen Sie sich die Stockscreener-App
12.69
2.23%
-0.29
Handel nachbörslich:
12.69
Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
19.52%
1.299
|
1.614 | 1.95 | 20.56 | 19.57 |
Operating Expenses
|
10.60%
43.51
|
48.66 | 48.80 | 42.35 | 41.23 |
| Benefits Costs and Expenses |
-
|
- | - | 37.91 | - |
| Costs And Expenses |
10.60%
43.51
|
48.66 | 48.80 | 37.91 | 41.23 |
| Operating Income/Loss |
10.29%
-42.21
|
-47.05 | -46.85 | -21.79 | -21.66 |
| Income/Loss From Continuing Operations Before Tax |
19.52%
1.299
|
1.614 | -43.10 | -17.35 | 19.57 |
| Income Tax Expense/Benefit |
85.93%
0.092
|
0.654 | 0.178 | - | -1.86 |
| Income/Loss From Continuing Operations After Tax |
11.26%
-39.16
|
-44.13 | -43.10 | -17.35 | -14.03 |
|
Net Income/Loss
|
11.26%
-39.16
|
-44.13 | -43.10 | -17.35 | -14.03 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.81%
0.0784
|
41.46 | 41.34 | 41.07 | 40.63 |
| Diluted Average Shares |
99.81%
0.0784
|
41.46 | 41.34 | 41.07 | 40.63 |
| Basic Earnings Per Share |
11.32%
-0.94
|
-1.06 | -1.04 | -0.42 | -0.35 |
| Diluted Earnings Per Share |
11.32%
-0.94
|
-1.06 | -1.04 | -0.42 | -0.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):